EVAX · Evaxion A/S ADR
United States · RS rating 38 · As of 2026-11-03
| Price | 2.96 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 43 / 65 / 22 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 18 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -300.0% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +55.4% |
| Market cap (USD) | $35.4M |